Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
Mood Disorders in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study.
复制标题
DOI:
10.1002/art.39111
复制
发表时间:
2015-07
影响因子:
13.3
通讯作者:
Farewell, Vernon
中科院分区:
文献类型:
--
作者:
Hanly, John G.;Su, Li;Urowitz, Murray B.;Romero-Diaz, Juanita;Gordon, Caroline;Bae, Sang-Cheol;Bernatsky, Sasha;Clarke, Ann E.;Wallace, Daniel J.;Merrill, Joan T.;Isenberg, David A.;Rahman, Anisur;Ginzler, Ellen M.;Petri, Michelle;Bruce, Ian N.;Dooley, M. A.;Fortin, Paul;Gladman, Dafna D.;Sanchez-Guerrero, Jorge;Steinsson, Kristjan;Ramsey-Goldman, Rosalind;Khamashta, Munther A.;Aranow, Cynthia;Alarcon, Graciela S.;Fessler, Barri J.;Manzi, Susan;Nived, Ola;Sturfelt, Gunnar K.;Zoma, Asad A.;van Vollenhoven, Ronald F.;Ramos-Casals, Manuel;Ruiz-Irastorza, Guillermo;Lim, S. Sam;Kalunian, Kenneth C.;Inanc, Murat;Kamen, Diane L.;Peschken, Christine A.;Jacobsen, Soren;Askanase, Anca;Theriault, Chris;Thompson, Kara;Farewell, Vernon
To determine the frequency, clinical and autoantibody associations and outcome of mood disorders in a multi-ethnic/racial, prospective, inception cohort of SLE patients. Patients were assessed annually for mood disorders (4 types as per DSM-IV) and 18 other neuropsychiatric (NP) events. Global disease activity (SLEDAI-2K), SLICC/ACR damage index (SDI) and SF-36 subscale, mental (MCS) and physical (PCS) component summary scores were collected. Time to event, linear and ordinal regressions and multi-state models were used as appropriate. Of 1,827 SLE patients, 88.9% were female, 48.9% Caucasian, mean ± SD age 35.1±13.3 years, disease duration 5.6±4.8 months and follow-up 4.73±3.45 years. Over the study 863 (47.2%) patients had 1,627 NP events. Mood disorders occurred in 232/1827 (12.7%) patients and 98/256 (38.3%) events were attributed to SLE. The estimated cumulative incidence of any mood disorder after 10 years was 17.7% (95%CI=[15.1%,20.2%]). There was a greater risk of mood disorder in patients with concurrent NP events (p ≤ 0.01) and lower risk with Asian race/ethnicity (p=0.01) and immunosuppressive drugs (p=0.003). Mood disorders were associated with lower mental health subscale and MCS scores but not with SLEDAI-2K, SDI scores or lupus autoantibodies. Antidepressants were used in 168/232 (72.4%) patients with depression. 126/256 (49.2%) mood disorders resolved in 117/232 (50.4%) patients. Mood disorders, the second most frequent NP event in SLE patients, have a negative impact on HRQoL and improve over time. The lack of association with global SLE disease activity, cumulative organ damage and lupus autoantibodies emphasize their multifactorial etiology and a role for non-lupus specific therapies.
登录
查看更多内容
影响因子:
27.4
作者:
Hanly JG;Urowitz MB;Su L;Bae SC;Gordon C;Wallace DJ;Clarke A;Bernatsky S;Isenberg D;Rahman A;Alarcón GS;Gladman DD;Fortin PR;Sanchez-Guerrero J;Romero-Diaz J;Merrill JT;Ginzler E;Bruce IN;Steinsson K;Khamashta M;Petri M;Manzi S;Dooley MA;Ramsey-Goldman R;Van Vollenhoven R;Nived O;Sturfelt G;Aranow C;Kalunian K;Ramos-Casals M;Zoma A;Douglas J;Thompson K;Farewell V;Systemic Lupus International Collaborating Clinics (SLICC)
通讯作者:
Systemic Lupus International Collaborating Clinics (SLICC)
影响因子:
3.1
作者:
Andrade, L;Caraveo-Anduaga, JJ;Wittchen, HU
通讯作者:
Wittchen, HU
影响因子:
--
作者:
Hanly, J. G.;Urowitz, M. B.;Merrill, J. T.
通讯作者:
Merrill, J. T.
影响因子:
27.4
作者:
Hanly, J. G.;Urowitz, M. B.;Farewell, V.
通讯作者:
Farewell, V.
影响因子:
3.3
作者:
Kellner, Erinn S.;Lee, Pui Y.;Reeves, Westley H.
通讯作者:
Reeves, Westley H.